Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.22
Delayed Data
As of 4:00pm ET
 +0.05 / +2.30%
Today’s Change
2.00
Today|||52-Week Range
7.50
-41.88%
Year-to-Date
Institutional investors purchased a net $4.5 million shares of RXII during the quarter ended December 2015 and now own 13.52% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders2.57%
Individual stakeholders2.37%
Other institutional10.96%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2016SIMPLEX TRADING LLC  Sold 1.0 Thousand shares of Rxi Pharmaceuticals Corp

Top 10 Owners of Rxi Pharmaceuticals Corp

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Broadfin Capital LLC7.85%5,126,4821,384,150-1,000,000-16.32%
The Vanguard Group, Inc.1.36%888,881239,998+27,300+3.17%
Frigate Ventures LP1.31%858,068231,678+858,068--
Renaissance Technologies LLC1.19%778,800210,276+198,800+34.28%
Perinvest (UK) Ltd.0.74%480,000129,600+480,000--
Geode Capital Management LLC0.41%266,38071,92300.00%
Pine River Capital Management LP0.22%145,00039,15000.00%
BlackRock Fund Advisors0.19%120,60732,564+11,833+10.88%
KCG Americas LLC0.10%68,18618,410-37,570-35.53%
Citadel Advisors LLC0.07%47,48412,821+47,484--

Top 10 Mutual Funds Holding Rxi Pharmaceuticals Corp

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change